Paternal DNA Methylation May Be Associated With Gestational Age at Begin
Background: How epigenetic modifications of DNA are associated to gestational age at supply is simply not completely understood. We investigated potential outcomes of differential paternal DNA methylation (DNAm) on offspring gestational age at supply by conducting an epigenome-wide look for cytosine-phosphate-guanine (CpG) web sites.
Methods: Analysis members on this analysis embody male cohort members or companions of the F1-generation of the Isle of Wight Begin Cohort (IoWBC). DNAm ranges in peripheral blood from F1-fathers (n = 92) collected spherical being pregnant of their spouses have been analyzed using the Illumina 450Okay array. A 5-step statistical analysis was carried out. First, a training-testing screening methodology was utilized to select CpG web sites which could be most likely associated to gestational age at supply.
Second, sensible enrichment analysis was employed to find out natural processes. Third, by centralizing on biologically informative genes, Cox proportional hazards fashions have been used to judge the hazard ratios of specific particular person paternal CpGs on gestational age adjusting for confounders. Fourth, to judge the validity of our outcomes, we in distinction our CpG-gestational age correlations inside a Born into Life Analysis in Sweden (n = 15). Lastly, we investigated the correlation between the detected CpGs and differential gene expression in F2 wire blood throughout the IoWBC.
Outcomes: Analysis of DNAm of fathers collected spherical their confederate’s being pregnant acknowledged 216 CpG web sites significantly associated to gestational age at supply. Sensible enrichment pathways analyses of the annotated genes revealed 2 natural pathways significantly related to cell-cell membrane adhesion molecules.
Differential methylation of 9 cell membrane adhesion pathway-related CpGs have been significantly associated to gestational age at supply after adjustment for confounders. The replication sample confirmed correlation coefficients of two pathway-related CpGs with gestational age at supply inside 95% confidence intervals of correlation coefficients in IoWBC. Lastly, CpG web sites of protocadherin (PCDH) gene clusters have been associated to gene expression of PCDH in F2 wire blood.
Conclusions: Our findings suggest that differential paternal DNAm may affect gestational age at supply by cell-cell membrane adhesion molecules. The outcomes are novel nonetheless require future replication in a much bigger cohort.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is unconjugated.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 390.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 488.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 565.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 594.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 633.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 655.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 680.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 700.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Alkaline Phosphatase.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to APC .
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to APC/Cy7.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Biotin.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Dylight 350.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Dylight 405.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Dylight 488.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Dylight 594.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Dylight 633.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to FITC.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to HRP.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to PE/ATTO 594.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to PerCP.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to RPE .
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA3742-3755). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Streptavidin.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is unconjugated.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 390.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 488.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 565.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 594.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 633.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 655.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 680.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to ATTO 700.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Alkaline Phosphatase.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to APC .
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to APC/Cy7.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Biotin.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Dylight 350.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Dylight 405.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Dylight 488.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Dylight 594.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Dylight 633.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to FITC.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to HRP.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to PE/ATTO 594.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to PerCP.
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to RPE .
Description: A polyclonal antibody for DNA PKcs from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of human DNA PKcs (AA4067-4081). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs antibody is conjugated to Streptavidin.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is unconjugated.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to ATTO 390.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to ATTO 488.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to ATTO 565.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to ATTO 594.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to ATTO 633.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to ATTO 655.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to ATTO 680.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to ATTO 700.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to Alkaline Phosphatase.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to APC .
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to APC/Cy7.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to Biotin.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to Dylight 350.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to Dylight 405.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to Dylight 488.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to Dylight 594.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to Dylight 633.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to FITC.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to HRP.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to PE/ATTO 594.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to PerCP.
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to RPE .
Description: A polyclonal antibody for DNA PKcs (pTyr883) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Tyr883 of human DNA PKcs (AA880-886). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pTyr883) antibody is conjugated to Streptavidin.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is unconjugated.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 390.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 488.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 565.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 594.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 633.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 655.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 680.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 700.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to Alkaline Phosphatase.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to APC .
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to APC/Cy7.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to Biotin.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to Dylight 350.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to Dylight 405.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to Dylight 488.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to Dylight 594.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to Dylight 633.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to FITC.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to HRP.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to PE/ATTO 594.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to PerCP.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to RPE .
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with Human A phospho-specific peptide corresponding to residues surrounding Thr2609 of human DNA PKcs (AA2606-2612). The Antibody is tested and validated for WB, AM assays with the following recommended dilutions: WB (1:250). This DNA PKcs (pThr2609) antibody is conjugated to Streptavidin.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is unconjugated.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 390.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 488.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 565.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 594.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 633.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 655.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 680.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to ATTO 700.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to Alkaline Phosphatase.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to APC .
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to APC/Cy7.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to Biotin.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to Dylight 350.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to Dylight 405.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to Dylight 488.
Description: A polyclonal antibody for DNA PKcs (pThr2609) from Human. The antibody is produced in rabbit after immunization with human synthetic phospho-peptide from human DNA PKcs around the phosphorylation site threonine 2609 (pThr2609) .. The Antibody is tested and validated for WB assays with the following recommended dilutions: WB (1:500-1500). This DNA PKcs (pThr2609) antibody is conjugated to Dylight 594.
×
Distinct contributions of DNA methylation and histone acetylation to the genomic occupancy of transcription elements
Epigenetic modifications on chromatin play important roles in regulating gene expression. Although chromatin states are generally dominated by multilayered building, how specific particular person pathways contribute to gene expression stays poorly understood. As an example, DNA methylation is known to handle transcription concern binding however along with recruit methyl-CpG binding proteins that affect chromatin building by the train of histone deacetylase complexes (HDACs).
Every of these mechanisms can most likely affect gene expression, nonetheless the importance of each, and whether or not or not these actions are built-in to understand acceptable gene regulation, stays largely unknown.
To cope with this important question, we measured gene expression, chromatin accessibility, and transcription concern occupancy in wild-type or DNA methylation-deficient mouse embryonic stem cells following HDAC inhibition.
We observe widespread will enhance in chromatin accessibility at retrotransposons when HDACs are inhibited, and that’s magnified when cells moreover lack DNA methylation. A subset of these parts has elevated binding of the YY1 and GABPA transcription parts and elevated expression.
The pronounced additive affect of HDAC inhibition in DNA methylation-deficient cells demonstrates that DNA methylation and histone deacetylation act largely independently to suppress transcription concern binding and gene expression.
Identification of the DNA Replication Regulator MCM Superior Expression and Prognostic Significance in Hepatic Carcinoma
Background: The microliposome repairs (MCM) superior, MCM2-7, is revealed to be involved in a variety of cellular processes and performs a key place throughout the progress and growth of human cancers. Nonetheless, the MCM superior stays poorly elaborated in hepatic carcinoma (HCC).
Methods: Throughout the analysis, we found the mRNA and protein diploma by bioinformatics. We moreover explored the prognostic price, genetic alteration, interaction group, and sensible enrichment of MCM2-7. The MCM expression and correlation amongst these MCMs in HCC cell strains have been acknowledged by western blot.
Outcomes: MCM2-7 was significantly elevated in HCC tissues as compared with common liver tissues. The extreme diploma of MCM2-7 had a constructive correlation with poor prognosis. Nonetheless, MCM2-7 alterations weren’t correlated with poor OS. MCMs have been every elevated in HCC cell strains as compared with the standard hepatocyte cell line. Furthermore, the constructive correlation was found amongst MCMs in HCC cell strains.
Conclusions: The MCM superior was elevated in HCC tissues and cell strains and negatively correlated with prognosis, which can be important biomarkers for HCC.
Construction, mechanism, and regulation of mitochondrial DNA transcription initiation
Mitochondria are specialised compartments that produce requisite ATP to gas mobile capabilities and function facilities of metabolite processing, mobile signaling, and apoptosis. To perform these roles, mitochondria depend on the genetic info of their small genome (mitochondrial DNA) and the nucleus.
A rising appreciation for mitochondria’s function in a myriad of human ailments, together with inherited genetic issues, degenerative ailments, irritation, and most cancers, has fueled the research of biochemical mechanisms that management mitochondrial perform. The mitochondrial transcriptional equipment is totally different from nuclear equipment.
The in vitro reconstituted transcriptional complexes of Saccharomyces cerevisiae (yeast) and people, aided with high-resolution constructions and biochemical characterizations, have offered a deeper understanding of the mechanism and regulation of mitochondrial DNA transcription.
On this evaluation, we are going to focus on latest advances within the construction and mechanism of mitochondrial transcription initiation. We are going to observe up with latest discoveries and formative findings concerning the regulatory occasions that management mitochondrial DNA transcription, specializing in these concerned in crosstalk between the mitochondria and nucleus.
A one-pot CRISPR/Cas9-typing PCR for DNA Detection and genotyping
The CRISPR/Cas9 has excessive specificity to its goal DNA as a gene enhancing software. This attribute makes it helpful for DNA detection. Combining the benefits of CRISPR/Cas9 and PCR, this research established a novel CRISPR/Cas9-based DNA detection methodology, named as CRISPR/Cas9-typing PCR model 4.0 (ctPCR4.0). This methodology can detect goal DNA in a single spot with excessive specificity and sensitivity.
In a homogenous response, the goal DNA is first cleaved by a pair of Cas9-sgRNA complexes and thus releases two single strands with free 3′ ends, permitting a pair of oligonucleotides to anneal with. The annealed oligonucleotides present templates for DNA polymerization from the free 3′ ends.
A common primer annealing website is thus produced on the finish of two single strands. Then the goal DNA is amplified by PCR utilizing a common primer. This methodology was first verified by precisely detecting the cloned L1 fragments of 10 genotypes of high-risk human papilloma viruses (hrHPVs). This methodology was then validated by detecting the L1 fragments of two highest-risk HPVs, HPV16 and HPV18, within the genomic DNA of two HPV-positive cervical carcinoma cells, HeLa and SiHa. Lastly, this methodology was additional validated by precisely detecting 10 hrHPVs in 30 medical samples.
Description: A polyclonal antibody for detection of GCFC1 from Human, Mouse. This GCFC1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GCFC1 protein
Description: A polyclonal antibody for detection of GCFC1 from Human, Mouse. This GCFC1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GCFC1 protein
Description: A polyclonal antibody for detection of GCFC1 from Human, Mouse. This GCFC1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GCFC1 protein
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced.
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19.
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012]
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined.
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described.
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer.
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced.
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19.
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene.
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids.
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species.
Description: A competitive Inhibition ELISA kit for detection of Anti-Anti-Sperm Antibody Antibody from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.
Description: The protein encoded by this gene is a member of the immunoglobulin/fibronectin type III repeat family. It is a component of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells, and promotes myogenic differentiation. Alternative splicing results in multiple transcript variants encoding different isoforms.
Description: The protein encoded by this gene is a member of the immunoglobulin/fibronectin type III repeat family. It is a component of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells, and promotes myogenic differentiation. Alternative splicing results in multiple transcript variants encoding different isoforms.
Description: Human bocavirus (also termed HBoV) is a small non-enveloped virus with a single- stranded DNA genome. It is a member of the Parvoviridae family. HBoV has been detected worldwide in 2–20 % of all upper and lower respiratory tract infections, and has also been linked to gastroenteritis.
Description: This gene encodes a serum protein found in association with the major histocompatibility complex (MHC) class I heavy chain on the surface of nearly all nucleated cells. The protein has a predominantly beta-pleated sheet structure that can form amyloid fibrils in some pathological conditions. The encoded antimicrobial protein displays antibacterial activity in amniotic fluid. A mutation in this gene has been shown to result in hypercatabolic hypoproteinemia.
Description: This gene encodes a serum protein found in association with the major histocompatibility complex (MHC) class I heavy chain on the surface of nearly all nucleated cells. The protein has a predominantly beta-pleated sheet structure that can form amyloid fibrils in some pathological conditions. The encoded antimicrobial protein displays antibacterial activity in amniotic fluid. A mutation in this gene has been shown to result in hypercatabolic hypoproteinemia.
